InvestorsHub Logo

bullhead88

01/12/17 1:29 AM

#35548 RE: fair231 #35547

Very goood news. They are doing a great job. Step by step. 2017 will be a great year for PPCH.
Remember also:
PPCH has some big names behind it; Klaus Kutz, CMO of Propanc has prepared multiple investigational new drugs (IND) FDA applications for Sanofi, a $48 stock. Dr. Ralph Brandt of Propanc successfully led the tumor biology program for animal studies at Novartis. Novartis is now trading at $98 a share.
Perfect Team...